Topics

Anika Announces $50 Million Share Repurchase Program

16:02 EDT 2 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, today announced that...

Other Sources for this Article

Anika Therapeutics, Inc.
Sylvia Cheung, 781-457-9000
Chief Financial Officer

NEXT ARTICLE

More From BioPortfolio on "Anika Announces $50 Million Share Repurchase Program"

Quick Search

Relevant Topics

Orthopedics
Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...